BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22009109)

  • 1. Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine.
    Luppi B; Bigucci F; Corace G; Delucca A; Cerchiara T; Sorrenti M; Catenacci L; Di Pietra AM; Zecchi V
    Eur J Pharm Sci; 2011 Nov; 44(4):559-65. PubMed ID: 22009109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nose-to-brain delivery of tacrine.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New environmental sensitive system for colon-specific delivery of peptidic drugs.
    Luppi B; Bigucci F; Cerchiara T; Mandrioli R; Di Pietra AM; Zecchi V
    Int J Pharm; 2008 Jun; 358(1-2):44-9. PubMed ID: 18359586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
    Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
    Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and optimization of chitosan nanoparticles and magnetic chitosan nanoparticles as delivery systems using Box-Behnken statistical design.
    Elmizadeh H; Khanmohammadi M; Ghasemi K; Hassanzadeh G; Nassiri-Asl M; Garmarudi AB
    J Pharm Biomed Anal; 2013 Jun; 80():141-6. PubMed ID: 23571126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hydrotropic β-cyclodextrin grafted hyperbranched polyglycerol co-polymer for hydrophobic drug delivery.
    Zhang X; Zhang X; Wu Z; Gao X; Cheng C; Wang Z; Li C
    Acta Biomater; 2011 Feb; 7(2):585-92. PubMed ID: 20813209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery.
    Sajeesh S; Sharma CP
    J Biomater Sci Polym Ed; 2007; 18(9):1125-39. PubMed ID: 17931503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
    Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P
    Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac.
    Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
    Pharmazie; 2011 Apr; 66(4):249-57. PubMed ID: 21612151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine serum albumin nanospheres carrying progesterone inclusion complexes.
    Luppi B; Cerchiara T; Bigucci F; Caponio D; Zecchi V
    Drug Deliv; 2005; 12(5):281-7. PubMed ID: 16188727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
    Garnero C; Zoppi A; Genovese D; Longhi M
    Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of cyclodextrin complexed hydroxyapatite nanoparticles for preferential albumin adsorption.
    Victor SP; Sharma CP
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):221-8. PubMed ID: 21458963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    Alzheimer Dis Assoc Disord; 2008; 22(2):116-24. PubMed ID: 18525282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle formation by using shellac and chitosan for a protein delivery system.
    Kraisit P; Limmatvapirat S; Nunthanid J; Sriamornsak P; Luangtana-anan M
    Pharm Dev Technol; 2013; 18(3):686-93. PubMed ID: 22568768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-β-cyclodextrin inclusion complex-loaded albumin nanoparticles.
    Gao S; Sun J; Fu D; Zhao H; Lan M; Gao F
    Int J Pharm; 2012 May; 427(2):410-6. PubMed ID: 22326299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer's disease.
    Wilson B; Samanta MK; Santhi K; Sampath Kumar KP; Ramasamy M; Suresh B
    J Neurosci Methods; 2009 Mar; 177(2):427-33. PubMed ID: 19041670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
    Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
    Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
    Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.